ArticleCancer medicine2019

Three-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: Pooled analysis of ONO-4538-05 and ONO-4538-06 studies.

Hidehito Horinouchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.